BioSpace News Archive

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of positive results from the pivotal, Phase 3, multi-center, randomized, double-blind double-dummy (DBDD) BouNDless trial of investigational ND0612.

Elligo Health Research®, the largest healthcare-enabling research organization, announced the addition of Barry Simms as Elligo’s Chief Operating Officer.

KUBTEC® Scientific, a leading digital X-ray imaging and irradiation system manufacturer, launched the latest advancement in benchtop irradiation systems - the XCELL® 180 X-ray Irradiator.

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the general availability of Linea™ IVT platform evaluation kits (the “Kit”) and the first shipment of a Kit to an existing Linea™ IVT Template customer.

Radiaction Medical, LTD, a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, made two announcements.

Marrow Access Technologies announced today that it signed a distribution agreement with Spartan Medical.

The Lung Cancer Research Foundation is pleased to announce the appointment of a select group of volunteers as its Research Advocates.

Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx™" or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome Ivory Chang as the Company’s Chief Regulatory Affairs Officer.

Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira”), a company dedicated to advancing acute respiratory care by enabling breathing without lungs, announced today that it has signed a further Service Agreement to supplement its previously announced Strategic Agreement with Innovimed Sp. z o.o (“Innovimed”) for planned clinical trials (clinical pilot studies) of the INSPIRA™ ART medical devices.